GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BioRegenx Inc (OTCPK:BRGX) » Definitions » Change In Receivables

BioRegenx (BioRegenx) Change In Receivables : $0.00 Mil (TTM As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is BioRegenx Change In Receivables?

BioRegenx's change in receivables for the quarter that ended in Mar. 2024 was $0.00 Mil. It means BioRegenx's Accounts Receivable declined by $0.00 Mil from Dec. 2023 to Mar. 2024 .

BioRegenx's change in receivables for the fiscal year that ended in Dec. 2023 was $0.00 Mil. It means BioRegenx's Accounts Receivable stayed the same from Dec. 2022 to Dec. 2023 .

BioRegenx's Accounts Receivable for the quarter that ended in Mar. 2024 was $0.10 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. BioRegenx's Days Sales Outstanding for the three months ended in Mar. 2024 was 15.21.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. BioRegenx's liquidation value for the three months ended in Mar. 2024 was $-3.11 Mil.


BioRegenx Change In Receivables Historical Data

The historical data trend for BioRegenx's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioRegenx Change In Receivables Chart

BioRegenx Annual Data
Trend Dec99 Dec00 Dec01 Dec02 Dec03 Dec04 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

BioRegenx Quarterly Data
Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 - - - -

BioRegenx Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioRegenx  (OTCPK:BRGX) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

BioRegenx's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0.103/0.618*91
=15.21

2. In Ben Graham's calculation of liquidation value, BioRegenx's accounts receivable are only considered to be worth 75% of book value:

BioRegenx's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0.114-3.505+0.75 * 0.103+0.5 * 0.409
=-3.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioRegenx Change In Receivables Related Terms

Thank you for viewing the detailed overview of BioRegenx's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


BioRegenx (BioRegenx) Business Description

Traded in Other Exchanges
N/A
Address
5051 Peachtree Corners Circle, No. 200, Peachtree Corners, GA, USA, 30092
Findit Inc owns Findit.com and the Findit App. Findit.com and the Findit App operate as a Social Media Content Management Platform, that includes its own search engine. Members can utilize Findit search to submit URLs they want Findit to index in Findit search results. Nonmembers can come to Findit and enter search queries, Findit returns matching search results from content posted in Findit along with outside web pages that have been submitted.

BioRegenx (BioRegenx) Headlines

From GuruFocus

Findit Featured Member BioRegenx Announces Investor Update

By ACCESSWIRE ACCESSWIRE 07-20-2022

Findit Inc Announces New Client � Rentalz.com

By ACCESSWIRE ACCESSWIRE 07-28-2022